yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. Angiogenesis
  5. EGFR

EGFR

EGFR

EGFR related products

Structure Cat No. Product Name CAS No. Product Description
Andamertinib V128813 Andamertinib 2254145-43-0 Andamertinib is an EGFR inhibitor with anti-tumor activity.
Bevasiranib sodium scrambled negative control V130105 Bevasiranib sodium scrambled negative control The Bevasiranib sodium scrambled negative control is a negative control with the sequence of bevasiranib sodium scrambled.
Biotin HER-2 substrate peptide V88961 Biotin HER-2 substrate peptide Biotin HER-2 substrate peptide is a substrate for HER4 and HER2/NEU tyrosine kinases, with a Km value of 60 μM for the HER2/NEU kinase domain.
CHNQD-01281 V118559 CHNQD-01281 2762488-97-9 CHNQD-01281 is a brevidin A derivative and an EGFR regulator.
Darlifarnib V133208 Darlifarnib 3065226-39-0 Darlifarnib is an orally effective farnesyltransferase inhibitor.
DSPE-PEG2000-Mal-Cys-ATWLPPR V134515 DSPE-PEG2000-Mal-Cys-ATWLPPR DSPE-PEG2000-Mal-Cys-ATWLPPR is a polyethylene glycol (PEG) compound composed of DSPE and a tumor angiogenesis-targeting peptide (A7R).
EGFR d746-750 Recombinant Human Active Protein Kinase V118907 EGFR d746-750 Recombinant Human Active Protein Kinase EGFR is a driver of tumorigenesis.
EGFR ligand-14-PEG3-Boc V119618 EGFR ligand-14-PEG3-Boc 2230825-46-2 EGFR ligand-14-PEG3-Boc contains an EGFR ligand and a linker group.
EGFR ligand-18 V114934 EGFR ligand-18 EGFR ligand-18 is a PROTAC target protein ligand that can be used to synthesize PROTACs, such as PROTAC EGFR degrader 16.
EGFR ligand-2 V84605 EGFR ligand-2 2737283-20-2
EGFR T790M/L858R-IN-3 V85416 EGFR T790M/L858R-IN-3
EGFR T790M/L858R-IN-9 V134930 EGFR T790M/L858R-IN-9 EGFR T790M/L858R-IN-9 is an EGFR-L858R/T790M inhibitor that exhibits potent phosphorylation inhibition of EGFR-L858R/T790M mutant kinase, with an IC50 value of 0.0064µM.
EGFR WT/T790M-IN-4 V134932 EGFR WT/T790M-IN-4 EGFR WT/T790M-IN-4 is an anticancer drug.
EGFR-IN-104 V103782 EGFR-IN-104 2758904-45-7 EGFR-IN-104 (Compound A23) is a potent EGFR inhibitor with IC50 values of 0.33 μM and 0.133 μM for EGFRL858R/T790M and EGFRDel19/T790M/C797S, respectively.
EGFR-IN-121 V99889 EGFR-IN-121 418799-16-3 EGFR-IN-121 (Compound 15) is a dual inhibitor of EGFR and VEGFR-2 with IC50 of 84 nM and 3.5 nM, respectively.
EGFR-IN-127 V94977 EGFR-IN-127 EGFR-IN-127 is an ATP-competitive EGFR inhibitor with IC50 of 136.3 nM and 161.2 nM for EGFRdel19 and EGFRdel19/T790M/C797S, respectively.
EGFR-IN-133 V93031 EGFR-IN-133 2809982-26-9 EGFR-IN-133 (Compound 24) is an inhibitor of EGFR, inhibiting EGFR wild-type, L858R/T790M, d19/T790M, L858R/T790M/C797S and d19/T790M/C797S mutants with IC50 of 0.1, 0.044, 0.036, 0.04 and 0.054 nM, respectively.
EGFR-IN-171 V118795 EGFR-IN-171 EGFR-IN-171 is an epidermal growth factor receptor (EGFR) inhibitor with an IC50 value of 0.19 μM.
EGFR-IN-183 V115928 EGFR-IN-183 EGFR-IN-183 (compound 5q) is an EGFR inhibitor.
EGFR-IN-186 V111346 EGFR-IN-186 EGFR-IN-186 is a potent EGFR inhibitor with an IC50 value of 0.065 µM.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: [email protected] Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member